In a genetic study examining the mutational status of the Ras and PI3K pathway genes in 40 breast cancer cell lines, mutations were detected at approximately 25% in Ras pathway members (KRAS, HRAS, NRAS, and BRAF) and 54% of PI3K pathway members (PTEN, PIK3CA). Here, PIK3CA is linked to breast carcinoma.